Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
BTTX Better Therapeutics
1.240-0.040-3.13%
Close
02/08 16:00 ET
High
1.316
Open
1.230
Turnover
41.16K
Low
1.210
Pre Close
1.280
Volume
32.48K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
SPAC Mountain Crest III Shareholders Approve ETAO Merger
Better Therapeutics Has Received A Decision To Grant European Patent Number EP3628101 Titled "Method And System For Managing Lifestyle And Health Interventions (For Addressing Body Weight And Cardiometabolic Disorders Such As Type-II Diabetes.)"
Better Therapeutics Has Received A Decision To Grant European Patent Number EP3628101 Titled "Method And System For Managing Lifestyle And Health Interventions (For Addressing Body Weight And Cardiome
Better Therapeutics, Inc. (NASDAQ:BTTX) Sees Large Increase in Short Interest
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 122,800 shares, an incr
Contrasting Better Therapeutics (BTTX) and The Competition
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 public companies in the "Health services" industry, but how does it contrast to its peers? We will compare Better Therapeutics to related b
Critical Survey: Better Therapeutics (BTTX) Versus Its Rivals
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 publicly-traded companies in the "Health services" industry, but how does it compare to its rivals? We will compare Better Therapeutics to
Critical Analysis: Better Therapeutics (BTTX) Versus Its Competitors
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 public companies in the "Health services" industry, but how does it compare to its competitors? We will compare Better Therapeutics to simi
Critical Review: Better Therapeutics (BTTX) and Its Peers
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 publicly-traded companies in the "Health services" industry, but how does it contrast to its peers? We will compare Better Therapeutics to
Comparing Better Therapeutics (BTTX) and Its Peers
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 public companies in the "Health services" industry, but how does it compare to its peers? We will compare Better Therapeutics to similar co
Head-To-Head Analysis: Better Therapeutics (BTTX) Vs. Its Competitors
Better Therapeutics (NASDAQ:BTTX – Get Rating) is one of 33 publicly-traded companies in the "Health services" industry, but how does it compare to its rivals? We will compare Better Therapeutics to
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Better Therapeutics, Inc. (BTTX)
Company Overview
More
Mountain Crest Acquisition Corp. II operates as a blank check company, which is formed for the purpose to acquire one or more businesses or entities. The company was founded on July 31, 2020 and is headquartered in New York, NY.
CEO： Mr. Frank L. Karbe
Market： NASDAQ
Listing Date： 01/07/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet